Mackenzie Financial Corp Has $556,000 Holdings in Pediatrix Medical Group, Inc. (NYSE:MD)

Key Points

• Mackenzie Financial Corp significantly increased its stake in Pediatrix Medical Group, acquiring an additional 17,376 shares, bringing its total to 38,399 shares valued at $556,000.
• Pediatrix Medical Group reported earnings per share (EPS) of $0.53, surpassing analyst estimates, but experienced a 7.1% decrease in revenue year-over-year.
• Market analysts have a consensus rating of "Hold" for Pediatrix Medical Group, with a target price of $16.67, reflecting mixed outlooks on the stock's performance.

Mackenzie Financial Corp grew its holdings in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 82.7% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 38,399 shares of the company's stock after purchasing an additional 17,376 shares during the quarter. Mackenzie Financial Corp's holdings in Pediatrix Medical Group were worth $556,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of MD. GAMMA Investing LLC raised its position in shares of Pediatrix Medical Group by 219.5% in the 1st quarter. GAMMA Investing LLC now owns 2,569 shares of the company's stock valued at $37,000 after acquiring an additional 1,765 shares during the period. Tower Research Capital LLC TRC raised its position in shares of Pediatrix Medical Group by 218.0% in the 4th quarter. Tower Research Capital LLC TRC now owns 7,445 shares of the company's stock valued at $98,000 after acquiring an additional 5,104 shares during the period. Squarepoint Ops LLC acquired a new stake in shares of Pediatrix Medical Group in the 4th quarter valued at approximately $132,000. Sherbrooke Park Advisers LLC acquired a new stake in shares of Pediatrix Medical Group in the 4th quarter valued at approximately $136,000. Finally, Hancock Whitney Corp acquired a new stake in shares of Pediatrix Medical Group in the 4th quarter valued at approximately $160,000. Institutional investors own 97.71% of the company's stock.

Pediatrix Medical Group Stock Up 3.3%

MD stock traded up $0.46 during mid-day trading on Tuesday, hitting $14.58. 149,810 shares of the company were exchanged, compared to its average volume of 746,651. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.80 and a current ratio of 1.80. The firm has a market cap of $1.27 billion, a P/E ratio of 11.31 and a beta of 1.21. The firm's 50 day simple moving average is $13.42 and its 200 day simple moving average is $13.82. Pediatrix Medical Group, Inc. has a 1-year low of $9.83 and a 1-year high of $17.67.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported $0.53 EPS for the quarter, topping the consensus estimate of $0.42 by $0.11. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. The firm had revenue of $468.84 million for the quarter, compared to the consensus estimate of $464.37 million. During the same period last year, the company posted $0.34 EPS. The business's quarterly revenue was down 7.1% on a year-over-year basis. On average, sell-side analysts predict that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

MD has been the topic of a number of analyst reports. UBS Group cut their price target on shares of Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating on the stock in a research report on Monday, May 12th. Macquarie raised their target price on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an "outperform" rating in a report on Thursday, May 8th. Four research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat.com, Pediatrix Medical Group presently has an average rating of "Hold" and an average target price of $16.67.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.